Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2010

View Archived Issues

MerLion Pharmaceuticals claims new macrolides

Astellas reports last year's product highlights

GE Healthcare identifies novel contrast agents for X-ray-based diagnosis

Novel antiviral compounds disclosed by GlaxoSmithKline

ACADIA describes new muscarinic acetylcholine receptor agonists

Merck & Co. identifies novel PDE10A inhibitors

Promising data reported on house dust mite allergy therapies

Zolpidem improves limb dystonia

Pridopidine beneficial in patients with Huntington's disease

ExonHit and Genmab sign agreement on new potential breast cancer targets

AMRI completes acquisition of Hyaluron

MultiCell contracts CDSS to manage phase IIb MCT-125 trial

GPR17 antagonist ticagrelor shows preclinical promise to treat demyelinating conditions

Endocyte presents interim phase I data on FR-targeting conjugates in solid tumors

Idarubicin/busulphan improves outcome of autograft in patients with NPM1-mutant AML

SCH-900105 is safe and advances from phase I to phase II trial

Promega and CDI validate predictive stem cell-based cardiotoxicity assays

FoldRx achieves funds to market tafamidis meglumine

Anacor reports on phase IIb trial of AN-2728 in psoriasis

Galera to advance dismutase mimetics for prevention of oral mucositis

EC grants QPI-1002 orphan status for prevention of DGF

Biogen enrolls first patient in phase II combination trial of BG-12 in MS

Pieris begins phase I trial of anticalin PRS-050 in cancer

Inovio begins immunization in phase I trial of VGX-3400X universal flu vaccine

EMA approves update to bortezomib label for multiple myeloma

Tranzyme and Norgine to codevelop ulimorelin in Europe and other regions

Anacor's AN-3365 achieves proof of concept in collaboration with GSK

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...